| Date | Ref. No. | Patent No. | Title |
| 11/10/2009 | E-192-2008/1 | | Optimized Expression of IL-12 Cytokine Family |
| 11/4/2009 | E-273-2009/0 | | Simpler is Better: The Production of Young Cell Cultures from Tumor Infiltrating Lymphocytes (TIL) Yields More Effective Adoptive Cell Transfer (ACT) Immunotherapies |
| 11/4/2009 | E-205-2009/0 | | Treating Cancer with Anti-Angiogenic Chimeric Antigen Receptors |
| 11/4/2009 | E-275-2002/1 | | Adoptive T-Cell Transfer After Lymphodepletion Promotes Tumor Regression |
| 11/3/2009 | E-083-2002/2 | | Use of Discoidin Domain Receptor 1 (DDR1) and Agents that Affect the DDR1/Collagen Pathway |
| 10/28/2009 | E-296-2009/0 | | Novel Inhibitors of Interleukin-6 for Kaposi Sarcoma Therapy |
| 10/27/2009 | E-295-2009/0 | | Prediction of Immune Response Outcomes to Keyhole Limpet Hemocyanin (KLH) Treatment |
| 10/12/2009 | E-163-2009/0 | | B-cell Surface Reactive Antibodies for the Treatment of B-Cell Chronic Lymphocytic Leukemia |
| 10/10/2009 | E-211-2005/0 | | Sensitizing Cancer Cells to DNA Targeted Therapies |
| 10/7/2009 | E-268-2007/0 | | A Fold-Back Diabody Format for Diphtheria Toxin-Based Immunotoxins That Can Increase Binding and Potency |
| 9/23/2009 | E-027-2005/0 | | Novel Chemoattractant-Based Toxins to Improve Vaccine Immune Responses for Cancer and Infectious Diseases |
| 9/23/2009 | E-110-2004/0 | 7,504,430 | Novel Agents Exhibiting Cytotoxicity Against Human Tumor Cell Lines |
| 9/9/2009 | E-089-2009/0 | | Immunogenic Tumor-associated Antigen SPANX-B for Selective Cancer Immunotherapy |
| 9/2/2009 | E-159-2009/0 | | Use of a Modified Adaptor Molecule LAT to Improve Immunotherapy for Cancer and Other Diseases |
| 8/14/2009 | E-063-2008/1 | | Nanoparticles for Imaging and Treatment of Brain Tumors |
| 7/29/2009 | E-157-2009/0 | | Treatment of Cancer Using Metal Coordinating Compounds that Kill Multi-Drug Resistant Cancer Cells |
| 7/29/2009 | E-250-2005/0 | | Methods for Treating or Ameliorating Fibrosis by Inhibiting the Interaction between IL-21 Receptor (IL-21R) and IL-21 |
| 7/29/2009 | E-040-2004/0 | 7,504,243 | High-yield Methods of Producing Biliverdin |
| 7/2/2009 | E-017-2008/0 | | Novel Compounds that Specifically Kill Multi-Drug Resistant Cancer Cells |
| 7/2/2009 | E-127-1995/0
E-127-1995/1
E-127-1995/2
E-138-1994/0
E-196-2004/0 | 6,884,871
6,924,367
7,049,291
7,148,036
7,220,558
7,563,596 | Novel Osteobiologic Proteins for Treatment of Osteoporosis, Rheumatoid and Neurologic Diseases |
| 7/2/2009 | E-042-2009/0 | | Immunogenic Peptide from NGEP Protein for Developing Prostate Cancer Vaccines |
| 7/2/2009 | E-033-2008/0 | | Therapeutic Applications of a p53 Isoform in Regenerative Medicine, Aging, and Cancer |
| 7/2/2009 | E-137-2002/0 | | Methods for Treating Cancer in Humans Using IL-21 |
| 6/30/2009 | E-243-2002/1 | | Recombinant Vaccinia Viruses Expressing IL-15 and Methods of Using the Same |
| 6/23/2009 | E-181-2009/0 | | New Inhibitors of Polo-like Kinase 1 (PLK1) as Anti-Cancer Agents |
| 6/23/2009 | E-170-2009/0 | | Increasing the Effectiveness of Cancer Treatment: T Cell Receptors Designed to Release Interleukin-12 Specifically at Cancer Sites |
| 6/11/2009 | E-164-2007/0 | | Compounds Binding to the N-Terminal Domains of STAT Proteins as Therapeutic Agents |
| 5/28/2009 | E-148-2009/0 | | Novel Method of Treating Cancer Using Ixolaris |
| 5/28/2009 | E-340-2008/0 | | Methods for Identifying Breast Cancer Patients for Therapy with mTOR Inhibitors |
| 5/28/2009 | E-043-2009/0 | | T Cells Attacking Cancer: T Cell Receptors that Recognize the Tyrosinase Tumor Antigen |
| 5/28/2009 | E-312-2007/1 | | New Weapons to Attack Cancer: T Cell Receptors Designed to Recognize Tumors with Enhanced Affinity |
| 5/15/2009 | E-325-2008/0 | | Mobilizing the Body to Fight Cancer: T Cell Receptors Specific for the Tumor Antigen Survivin |
| 5/15/2009 | E-025-1998/0 | 6,610,684 | Fused Azepinone Cyclin Dependent Kinase Inhibitors |
| 5/11/2009 | E-304-2006/0 | | Enhanced Function of Gene Modified T-Cells: Identification of T-Cell Receptors (TCR) with Altered Amino Acid Sequence |
| 5/5/2009 | E-326-2008/0 | | Small Molecule Activators of Human Pyruvate Kinase for Treatment of Cancer and Enzyme-Deficient Hemolytic Anemia |
| 5/5/2009 | E-179-2008/0 | | Salcut-NH2: A Novel Target for Development of Anti-Tumorigenic, Anti-Angiogenic Therapeutics and Diagnostics |
| 5/5/2009 | E-092-2008/0 | | Novel Oligonucleotides for Treatment of Human Cancer |
| 5/4/2009 | E-257-2004/0 | | Modulating Expression of the Metastasis Suppressor MxA |
| 5/4/2009 | E-223-2006/1
E-284-2008/0 | | Small-Molecule TSH Receptor Modulators for Diagnosis and Treatment of Thyroid Disease and Cancer |
| 5/4/2009 | E-045-2009/0 | | Treating Cancer through Immunotherapy with Herceptin-Based Receptors Specific for ErbB2 (Her2/Neu) |
| 5/4/2009 | E-336-2008/0 | | Peptides for Treating Mesothelin- and/or CA125-Expressing Cancers |
| 5/4/2009 | E-324-2008/0 | | Selective Killing of Cancer Cells By Inhibition of Geminin |
| 5/4/2009 | E-053-2006/0 | | Polyclonal Antibody Against Bloom's Syndrome Protein (BLM) for Research and Diagnostic Use |
| 5/4/2009 | E-193-1997/0 | 6,555,367 | Targeted Recombinant Adenoviral Vectors |
| 3/23/2009 | E-247-2008/0 | | Lasonolide Compounds as Reagents for Inducing Premature Chromosome Condensation and Methods of Treating Cancer |
| 2/25/2009 | E-302-2008/0 | | Prevention of Head and Neck Cancer Using Rapamycin and Its Analogs |
| 2/2/2009 | E-185-2008/0 | | HMGN Polypeptides as Immune Enhancers and HMGN Antagonists as Immune Suppressants |
| 2/2/2009 | E-123-2008/0 | | Substituted IL-15 |
| 1/9/2009 | E-182-2008/0 | | Method of Treating Pneumoconiosis with Oligodeoxynucleotides |
| 1/9/2009 | E-278-2007/0 | | Attenuated Salmonella as a Delivery System for siRNA-Based Tumor Therapy |
| 1/5/2009 | E-295-2008/0 | | Novel Inhibitor of NF-kappa B Pathway |
| 1/1/2009 | E-274-2008/0 | | Monoclonal Antibodies to the Tumor-Specific Antigen, Human ROR1 |
| 1/1/2009 | E-051-2008/0 | | A Novel and Efficient Technology for Targeted Delivery of siRNA |
| 12/1/2008 | E-003-2008/0 | | A Novel, Non-Invasive and Therapeutically Useful High Throughput Technique to Isolate Highly Enriched Tumor Reactive Lymphocytes from Peripheral Blood - Potential Use in Adoptive Immunotherapy |
| 12/1/2008 | E-034-2002/0 | 7,365,160 | Mutant Nuclear Orphan Receptor for Drug Metabolism Assays |
| 11/1/2008 | E-211-2008/0 | | Fully Human Anti-Human Monoclonal Antibody Helpful in Developing Therapies Against Autoimmune and Infectious Diseases and Cancer |
| 11/1/2008 | E-250-2007/0 | | Induced Internalization of Surface Receptors |
| 11/1/2008 | E-166-2007/0 | | Discovery of and Use of Fragments of DOC1 as Antiangiogenic and Antitumor Therapy |
| 11/1/2008 | E-174-2008/0 | | Therapeutic Targeting of CSN5, a Negative Regulator of p53 and p27, in Human Hepatocellular Carcinoma |
| 11/1/2008 | E-256-1999/0 | | Methods for Accurately Measuring and Regulating Bound Adrenomedullin |
| 10/1/2008 | E-065-2008/0 | | Association of the ECHDCI/RNF146 Gene Region on Human Chromosome 6q with Breast Cancer Risk and Protection |
| 9/1/2008 | E-163-2007/0 | | Bifunctional Compounds that Bind to Hormone Receptors |
| 9/1/2008 | E-175-2008/0 | | Over-expression and Mutation of a Tyrosine Kinase Receptor FGFR4 in Tumors |
| 9/1/2008 | E-332-2007/0 | | Small Molecule Inhibitors of c-Met |
| 9/1/2008 | E-139-1999/0 | 7,081,518 | A Novel Recombinant Immunotoxin SS1P (anti-mesothelin dsFv-PE38): A Therapeutic Treatment for Lung Cancer and Other Mesothelin Expressing Cancers |
| 9/1/2008 | E-147-2008/0 | | Cyclized NGR Peptide for Tumor Targeting |
| 9/1/2008 | E-213-2001/2 | 7,361,664 | Vitamin D Receptor Antagonists for Treating Breast Cancer |
| 8/1/2008 | E-249-2005/0 | | Methods of Treating and Preventing Renal Cancer using a Dimethane Sulfonate Compound |
| 8/1/2008 | E-285-2006/2 | | New Tumor Endothelial Markers: Genes that Distinguish Physiological and Pathological Angiogenesis |
| 8/1/2008 | E-062-1996/0
E-099-1996/0
E-154-1998/0
E-200-1990/3
E-200-1990/4
E-256-1998/0
E-256-1998/1
E-259-1994/3
E-259-1994/4
E-260-1994/1 | 6,001,349
6,045,802
6,165,460
6,319,496
6,548,068
6,756,038
6,893,869
6,946,133
6,969,609
7,118,738
7,211,432
7,368,116
7,410,644
7,547,773
7,598,225 | Enhanced T-cell Activation by Costimulation: A Potentially Novel Approach for the Prevention and/or Therapy of Cancer (Excluding Prostate Diseases and Melanoma) and for Infectious Diseases |
| 8/1/2008 | E-194-2008/0 | | Immunotoxins Made with Modified Cholix Toxin and Uses Thereof |
| 8/1/2008 | E-274-2003/0 | | 2-Amino-O4-Substituted Pteridines: Improved Chemotherapy Adjuvants |
| 8/1/2008 | E-262-2000/0
E-262-2000/1 | 6,977,241
7,425,537 | SH2 Domain Binding Inhibitors |
| 7/1/2008 | E-282-2007/0 | | TGF-beta Gene Expression Signature in Cancer Prognosis |
| 7/1/2008 | E-150-2007/0 | | A Novel Therapeutic Strategy for the Treatment of Hyperpigmentation and Melanoma |
| 7/1/2008 | E-263-2004/0 | | A New Pot1 Variant Gene as a Diagnostic Biomarker for Hereditary Non-polyposis Colorectal Cancer |
| 7/1/2008 | E-321-2006/0 | | Treatment of Skin Conditions Using DKK1 |
| 6/1/2008 | E-292-2007/0 | | Immunotoxins with Deletions in Domain II that Remove Immunogenic Epitopes with Minimal Loss of Cytotoxic Activity |
| 5/1/2008 | E-096-2000/0 | 7,531,352 | The Use of an Inducible Plasmid Vector Encoding for Active TGF-beta for the Treatment of Autoimmune Diseases |
| 5/1/2008 | E-120-2003/2 | 7,378,276 | Method of Inducing Memory B Cell Development and Terminal Differentiation |
| 5/1/2008 | E-080-2008/0 | | Human and Improved Murine Monoclonal Antibodies Against CD22 |
| 5/1/2008 | E-079-2008/0 | | Human Monoclonal Antibody Against Mesothelin |
| 5/1/2008 | E-129-2008/0 | | Synthetic Analogs of Juxtamembrane Domain of IGF-1 Receptor as Anti-Cancer Agents |
| 5/1/2008 | E-265-1999/2 | | Inhibition of Cell Motility, Angiogenesis and Metastasis |
| 5/1/2008 | E-316-2007/0 | | Method of Inhibiting ABCG2 and Related Treatments |
| 5/1/2008 | E-265-2007/0 | | Telomerase Suppressor Compositions and Methods for Diagnosis and Treatment of Cancer |
| 5/1/2008 | E-206-1995/3 | 6,320,022
7,101,548 | Treatment and Diagnosis of Cancer, Diabetes and other Disorders Using Adrenomedullin Peptides and Antibodies |
| 4/1/2008 | E-003-2007/0 | | Engineered Human Antibody Constant Domains (Nanoantibodies) as Scaffolds for Binders |
| 2/1/2008 | E-137-2006/0
E-137-2006/1 | | Manganese Superoxide Dismutase VAL16ALA Polymorphism Predicts Resistance to Doxorubicin Cancer Therapy |
| 2/1/2008 | E-019-2005/0 | | Synergistic Effect of TGF-beta Blockade and Immunogenic Agents on Tumors |
| 2/1/2008 | E-315-2007/0 | | New Inhibitors of Multidrug Resistant Proteins Such As ABCG2 |
| 2/1/2008 | E-208-2007/0 | | Eeyarestatins: Novel Deubiquitination Inhibitors for the Treatment of Drug-Resistant Cancers |
| 2/1/2008 | E-203-2000/0 | 7,144,918 | Biologically Active Macrolides, Compositions and Uses Thereof |
| 1/1/2008 | E-084-1991/1 | 3715313
6,274,134
684806 | Antibodies and Polypeptides Specific to AAMP-1: Diagnostic and Therapeutic Uses Thereof |
| 1/1/2008 | E-108-2007/0 | | Photosensitization by Nuclear Receptor-Ligand Complexes and Cell Ablation Uses Thereof |
| 1/1/2008 | E-008-2008/0 | | Diagnosis and Treatment of Barrett's Esophagus and Associated Esophageal Adenocarcinoma |
| 12/1/2007 | E-168-2007/0 | | Treatment for Chronic Inflammatory Disease and Cancer by Inhibition of MMP-1 |
| 11/1/2007 | E-074-2007/0 | | Human T-box Transcription Factor Brachyury as a Target for Cancer Immunotherapy: Identification of Epitopes of Human Brachyury as Targets for T-cell Mediated Lysis of Tumors |
| 11/1/2007 | E-177-2006/0 | 7,553,936 | A Novel, Inhibitory Platelet Surface Protein (TREM Like Transcript, TLT-1): New Target for the Treatment of Cancer, Infectious Diseases, Cardiac Diseases, and Platelet-Associated Disorders |
| 11/1/2007 | E-061-2007/0 | | Diagnostic Ovarian Cancer Biomarkers |
| 11/1/2007 | E-139-1999/0 | 7,081,518 | A Clinically Proven Therapeutic Treatment and Diagnostic Tool for Mesothelin Expressing Cancers: A Novel Recombinant Immunotoxin SS1P (anti-mesothelin dsFv-PE38) |
| 11/1/2007 | E-302-2007/0 | | A Family of Small Molecules for Selective Inhibition of Wip1 Phosphatase |
| 11/1/2007 | E-232-1995/0
E-232-1995/1 | 5,658,744
5,965,366 | A New Method for Determining Level of Immunosuppression in Humans |
| 11/1/2007 | E-135-2006/1
E-303-2003/0 | | Inactivation of Enveloped Viruses and Tumor Cells for Infectious Disease and Cancer Vaccines |
| 10/1/2007 | E-064-2005/0 | | Biomarkers for Tissue Status |
| 10/1/2007 | E-084-2007/0 | | Use of HDAC Inhibitors for the Prevention and Cure for Brain Metastases of Cancers |
| 9/1/2007 | E-137-2005/0 | | Methods and Compositions for Treating FUS1 Related Disorders |
| 9/1/2007 | E-200-2007/0 | | New and Improved Chemotherapy Adjuvants: Folate Based Inactivators of O6-alkylguanine-DNA alkyltransferase (alkyltransferase) |
| 9/1/2007 | E-272-1998/0 | 6,790,948
7,431,926 | Tumor Suppressor Genes |
| 9/1/2007 | E-161-2007/0 | | Treatment of Primary Tumors and Tumor Metastases with TNF-alpha Antagonists |
| 9/1/2007 | E-153-1998/0 | 7,256,256 | Peptide Inhibitor of Cyclin Dependent Kinase 4 (CDK4) Derived from MyoD |
| 8/1/2007 | E-080-2006/0 | | A New Series of Thalidomide Analogs That Have Potent Anti-Angiogenic Properties |
| 8/1/2007 | E-104-2006/0 | | Immunogenic Peptides and Methods of Use for Treating Prostrate and Uterine Cancers |
| 8/1/2007 | E-028-1999/0 | 7,399,827 | Diagnostic and Therapeutic Methods of Detecting and Treating Cancers of Reproductive Tissues |
| 8/1/2007 | E-215-2007/0 | | Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells |
| 8/1/2007 | E-068-1998/0 | 6,685,933
7,235,232 | Interferon Alpha Hybrids |
| 8/1/2007 | E-180-2000/0 | 6,939,547
7,108,981
7,235,365
7,374,756 | Specific Binding Agents for KSHV vIL-6 that Neutralize a Biological Activity |
| 7/1/2007 | E-118-2005/0 | | A Gene Therapy to Treat Lung Cancer |
| 7/1/2007 | E-265-2005/0 | | Modification of Recombinant Anti-tumor RNase (rapLR1) for Optimal Use in the Large Scale Manufacture of Stable and Potent RapLR1-Antibody Conjugates |
| 7/1/2007 | E-288-2006/0 | | Cyclic Phosphopeptide Inhibitors of Protein Phosphatase 2C Delta, Wip1 |
| 6/1/2007 | E-117-2006/0 | | Diagnostic and Therapeutic Use of Brother of the Regulator of Imprinted Sites (BORIS) Alternative Splice Forms |
| 6/1/2007 | E-042-1998/0 | 6,897,018
7,534,565 | DLC-1 Gene Deleted in Cancers |
| 6/1/2007 | E-098-2007/0 | | Synthetic Macrolides Inhibit Breast Cancer Migration |
| 6/1/2007 | E-012-1991/0
E-012-1991/2
E-044-1997/0
E-044-1997/1 | 5,167,956
5,725,857
6,632,928 | Immunotoxin with in-vivo T cell Suppressant Activity |
| 6/1/2007 | E-060-2007/0 | | A Gene Expression Profile that Predicts Ovarian Cancer Patient Response to Chemotherapy |
| 6/1/2007 | E-160-2006/0 | | Potent, Easy to Use Targeted Toxins as Anti-Tumor Agents |
| 6/1/2007 | E-012-1991/0
E-012-1991/4
E-012-1991/7
E-044-1997/0
E-044-1997/1
E-059-1998/0
E-168-1999/0 | 5,167,956
5,762,927
6,103,235
6,632,928
7,288,254 | Methods of Inducing Immune Tolerance Using Immunotoxins |
| 6/1/2007 | E-310-2001/0 | | Identification of Ovarian Cancer Tumor Markers and Therapeutic Agents |
| 5/1/2007 | E-082-2005/0
E-082-2005/2 | | Sipa-Gene and Sipa-1 Inhibitor for the Diagnosis and Treatment of Metastatic Cancer |
| 5/1/2007 | E-019-2000/0
E-019-2000/1
E-019-2000/2 | | Inhibition of ABC Transporters by Transmembrane Domain Analogs |
| 5/1/2007 | E-018-2005/2 | | Diagnosing and Treating Cancer Using beta-Catenin Splice Variants |
| 5/1/2007 | E-287-2004/1 | | Novel Diagnostics and Therapeutics for Various Hematologic Malignancies: Monoclonal Antibodies to Members of Fc receptor-like (FCRL) Proteins |
| 5/1/2007 | E-070-2005/0 | | Inhibitors of Ubiquitin E1 |
| 5/1/2007 | D-001-1996/1
D-001-2006/0
D-003-1992/2
D-003-1992/3
D-004-1992/0
D-004-1992/1
E-259-1998/2 | 5,472,693
5,877,291
5,892,020
6,051,225
6,071,515
6,207,815
6,329,507
6,348,581
6,737,060
6,737,061
6,752,990
6,753,152
6,753,420
6,818,749
628078
7,256,004 | Humanized Anti-Carcinoma CC49 Monoclonal Antibodies |
| 5/1/2007 | E-062-1996/0
E-099-1996/0
E-154-1998/0
E-200-1990/3
E-200-1990/4
E-256-1998/0
E-256-1998/1
E-259-1994/3
E-259-1994/4
E-260-1994/1 | 6,001,349
6,045,802
6,165,460
6,319,496
6,548,068
6,756,038
6,893,869
6,946,133
6,969,609
7,118,738
7,211,432
7,368,116
7,410,644
7,547,773
7,598,225 | Enhanced T-cell Activation by Costimulation: An Effective Immunotherapy for Cancer and Infectious Diseases |
| 5/1/2007 | E-307-2004/1 | | Aminoalkyl Substituted O6-Benzylguanine Derivatives as Inactivators of O6-Alkylguanine-DNA Alkyltransferase and Adjuvants for Chemotherapy |
| 4/1/2007 | E-059-2007/2 | | New Mouse T Cell Receptors as Potential Therapeutic Agents for the Treatment of Metastatic Cancer |
| 4/1/2007 | E-271-2006/0 | | A Novel DNA Vaccine for the Treatment of Malignancies Expressing Immature Laminin Receptor Protein |
| 4/1/2007 | E-103-2000/0
E-103-2000/1
E-103-2000/2
E-305-2005/0 | 6,753,317
6,916,905 | Novel Dmt-Tic Analogues Specific for Delta- and Mu-Opioid Receptors |
| 3/1/2007 | E-323-2004/0 | | Arylthioindole Tubulin Polymerization Inhibitors and Methods of Treating or Preventing Cancer Using Same |
| 3/1/2007 | E-314-2003/0
E-314-2003/1
E-314-2003/2 | | Identification and Isolation of the Receptor for Pigment Epithelium-derived Factor (PEDF) |
| 3/1/2007 | E-148-2003/0 | 7,572,887 | Genes Expressed in Prostate Cancer and Methods of Use |
| 2/1/2007 | E-107-1998/0 | 6,562,347 | Methods and Compositions of Chemokine-Tumor Antigen Fusion Proteins as Cancer Vaccines |
| 2/1/2007 | E-070-2007/2 | | Human Cancer Therapy Using Engineered Anthrax Lethal Toxin |
| 2/1/2007 | E-138-2006/0 | | Highly Soluble Pyrimido-Dione-Quinoline Compounds: Small Molecules that Stabilize and Activate p53 in Transformed Cells |
| 2/1/2007 | E-317-2004/1 | | Metal Chelators and Target-Moiety Complexes for Imaging |
| 1/1/2007 | E-132-2006/0
E-132-2006/1
E-132-2006/2 | | A New Method for Improving the Therapeutic Efficacy of L-Asparaginase in Multiple Types of Cancer |
| 1/1/2007 | E-213-1987/1 | 5,616,471 | Methods for Assaying Hair Follicle Growth and Development |
| 1/1/2007 | E-183-2004/1 | | Enriched Natural Killer Cells for Adoptive Infusion Cancer Therapy |
| 12/1/2006 | E-347-2004/0 | | ARH3, a Therapeutic Target for Cancer, Ischemia, and Inflammation |
| 12/1/2006 | E-014-2007/0 | | Peptide and Peptidomimetic Inhibitors of Smoothened Protein as Anti-neoplastic Agents |
| 12/1/2006 | E-125-2006/1 | | Extracellular Matrix/Metastasis Modifier Genes as a Method for Characterization and Prevention of Metastatic Tumor |
| 12/1/2006 | E-311-2006/1 | | Chitosan as a Universal Vaccine Adjuvant, Antigen Depot and Cytokine Depot |
| 10/1/2006 | E-027-2006/0 | | PDE11A as a Novel Therapeutic Target for Inherited Form of Cushing Syndrome and Endocrine Tumors |
| 9/1/2006 | E-200-2006/0 | | Mammalian Cell Surface Display of Fvs for Rapid Antibody Maturation |
| 9/1/2006 | E-265-1997/0 | 7,084,239 | Cancer Peptides of NY-ESO-1/CAG-3 |
| 8/1/2006 | E-340-2004/0
E-340-2004/2 | | Adoptive Immunotherapy with T Lymphocytes Engineered for Enhanced Survival |
| 8/1/2006 | E-201-2006/1 | | Diagnostic and Therapeutic Strategies for Metastatic Hepatocellular Carcinoma by Targeting Osteopontin |
| 8/1/2006 | E-086-2006/0 | | Hybrid T-Cell Receptors for the Development of Improved Vaccines |
| 6/1/2006 | E-097-2006/0
E-097-2006/1 | | Use of Tetracyclines as Anti-Cancer Agents |
| 6/1/2006 | E-091-2004/0 | | Ultrasonic Waves with Nanovessels or Tethered Nanotube/Monoclonal Antibody Composites for Cancer Therapy |
| 6/1/2006 | E-090-2004/0 | | Radio-Activated Boron-Nitride Nanotube-Antibody Conjugates for Cancer Therapy and Diagnostics |
| 6/1/2006 | E-122-2006/0 | | Agonist Epitopes for Renal Cell Carcinoma |
| 6/1/2006 | E-336-2005/0 | | Novel Human IGF-1 Specific IGF-I and IGF-II Cross-Reactive Human Monoclonal Antibodies as Potential Anti-tumor Agents |
| 6/1/2006 | E-165-2006/0 | | Diamidine Inhibitors of Tdp1 as Anti-Cancer Agents |
| 6/1/2006 | E-053-1996/0 | 6,982,168 | Immortal Human Prostate Epithelial Cell Cultures as a Prostate Cancer Model |
| 5/1/2006 | E-200-2005/0 | | Insect Cell Production of Recombinant Adeno-Associated Virus that Produce Cytotoxic Gene Products and Applications for Solid Tumor Therapy |
| 5/1/2006 | E-139-2005/0 | | Identification of a Novel Folliculin Interacting Protein, FNIP-1 |
| 5/1/2006 | E-106-2006/3 | | T-cell Receptor Recognizing Renal Cell Carcinoma |
| 5/1/2006 | E-094-2006/0 | | Preparation of a Peptide Targeted Human RNase, RGD-Eosinophil Derived Neurotoxin (RGD-EDN) To Specifically Target Tumor Vasculature |
| 5/1/2006 | E-090-2006/0 | | Adoptive Immunotherapy with Autologous Natural Killer Cells |
| 5/1/2006 | E-055-1999/0 | 6,680,176 | Identification of Candidate Ligands which Modulate Antigen Presenting Cells |
| 5/1/2006 | E-176-1998/1 | | Anti-Notch-1 Monoclonal Antibodies for Inducing Cellular Differentiation and Apoptosis |
| 3/1/2006 | E-319-2005/0 | | Methods of Treating Cancer Using Pyridine Carboxaldehyde Pyridine Thiosemicarbazone Radiosensitizing Agents |
| 3/1/2006 | E-262-1999/1 | 7,459,536 | Monoclonal Antibodies Which Specifically Bind to the Ligand Hepatocyte Growth Factor (HGF) and are Useful in the Treatment of Cancer |
| 3/1/2006 | E-312-2005/0 | | Immunogenic Peptides and Methods of Use for Treating and Preventing Cancer |
| 2/1/2006 | E-146-1992/0 | 6,040,334 | Use of Inhibitors of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase as a Modality in Cancer Therapy |
| 2/1/2006 | E-218-2005/0 | | Methodology for Large Scale Manufacture of Stable Disulfide-Conjugated Antibody-Ribonuclease |
| 2/1/2006 | E-106-2005/0 | | Identification of Biomarkers by Serum Protein Profiling |
| 2/1/2006 | E-065-2002/0 | | ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma |
| 2/1/2006 | E-104-1998/0 | 6,060,458 | Oligodeoxyribonucleotides Comprising O6-Benzylguanine and Their Use |
| 1/1/2006 | E-163-2005/0 | | Intraperitoneal Injection of Pseudovirions Carrying a Toxin Leads to Significantly Reduced Tumor Size |
| 1/1/2006 | E-067-1995/0 | 5,610,185 | Treatment of Hyperproliferative Epithelial Skin Diseases by Topical Application of Hydroxylated Aromatic Protein Cross-Linking Compounds |
| 1/1/2006 | E-014-1991/0 | 7,056,908 | Pharmaceutical Compositions and Methods for Preventing Skin Tumor Formation and Causing Regression of Existing Tumors |
| 12/1/2005 | E-058-2005/0 | | Synthesis of Indenoisoquinoliniums and Methods of Use |
| 12/1/2005 | E-323-2003/0 | 7,589,181 | Minimally Immunogenic Variants of SDR-Grafted Humanized Antibody CC49 and Their Use |
| 12/1/2005 | E-142-1990/2 | 5,731,167
6,084,069
6,417,338 | Autotaxin: Motility Stimulating Protein Useful in Cancer Diagnosis and Therapy |
| 12/1/2005 | E-003-2006/0 | | Antibodies and Immunotoxins that Target Human Glycoprotein NMB |
| 12/1/2005 | E-142-2005/0 | | A Single Ribozyme to Catalyze both Trimming and Transacting Catalysis - Potential Therapeutic for HPV Infection and Cervical Cancer |
| 11/1/2005 | E-217-2005/0 | | Antibodies Against Insulin-Like Growth Factor II and Uses Thereof |
| 11/1/2005 | E-272-2002/0
E-272-2002/1 | 7,439,226 | Serine Protease Inhibitors |
| 11/1/2005 | E-192-2004/0 | | Compositions and Methods for Diagnosis and Treatment of Chemotherapy-Resistant Neoplastic Disease |
| 10/1/2005 | E-065-2005/0 | | Novobiocin Analogues as Anticancer Agents |
| 10/1/2005 | E-266-1994/1 | 6,428,788 | Compositions and Methods of Specifically Targeting Tumors |
| 10/1/2005 | E-110-1992/0 | 5,272,146
5,441,941 | 1,2-Dihydroellipticines with Activity Against CNS-Specific Cancer Cell Lines |
| 10/1/2005 | E-262-2005/0 | | Mutated Pseudomonas Exotoxins with Reduced Antigenicity |
| 10/1/2005 | E-167-1997/0 | 7,153,866 | The Use of Nitroxides in the Prophylactic and Therapeutic Treatment of Cancer Due to Genetic Defects |
| 10/1/2005 | E-081-2001/0
E-081-2001/1
E-081-2001/2 | | Zebularine, A Stable and Orally Active Inhibitor of Cytosine DNA Methyltransferase Capable of Reactivating Dormant Tumor Suppressor and Inhibiting Tumor Growth |
| 9/1/2005 | E-327-2004/0 | | A New Approach Toward Macrocyclization of Peptides |
| 9/1/2005 | E-181-1999/0 | 7,208,313 | A Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector for Cancer Therapy |
| 9/1/2005 | E-144-2005/0 | | Soluble Fragments of the IGF1R Ectodomain |
| 9/1/2005 | E-121-2005/0 | | Polymer-linked Pseudomonas Exotoxin Immunotoxin |
| 9/1/2005 | E-095-2000/2 | | Amelioration of Inflammatory Arthritis Targeting the Pre-ligand Assembly Domain (PLAD) of Tumor Necrosis Factor Receptors |
| 9/1/2005 | E-087-1996/0 | | Heterologous Boosting Immunizations |
| 9/1/2005 | E-009-1991/0
E-009-1991/1
E-301-1998/2 | 5,217,953
5,565,424 | Cancer Therapy Using Vasoactive Intestinal Peptide Antagonists |
| 9/1/2005 | E-315-2003/0 | | SH2 Domain Binding Inhibitors (E-315-2003) |
| 9/1/2005 | E-013-1998/0 | 6,943,191 | Disubstituted Lavendustin A Analogs and Pharmaceutical Compositions Comprising the Analogs |
| 9/1/2005 | E-060-2002/2 | | DNA-Binding Polyamide Drug Conjugates |
| 9/1/2005 | E-188-1998/1 | 6,136,992 | Novel 2-Alkoxy Estradiols and Derivatives Thereof |
| 9/1/2005 | E-244-1997/0
E-244-1997/3 | 6,353,019
7,381,744 | Antitumor Macrocyclic Lactones / Vacuolar-Type (H+)-ATPase-Inhibiting Compounds and Uses Thereof |
| 9/1/2005 | E-291-2003/0 | | New Building Blocks for DNA Binding Agents |
| 8/1/2005 | E-155-2005/0
E-155-2005/1
E-155-2005/2
E-155-2005/3 | | Immunogenic Peptides From Human Papillomavirus Type 16 E2 |
| 8/1/2005 | E-046-2005/0 | | A Novel Interleukin-12 (IL-12) Inducing Protein Isolated from Toxoplasma gondii Inflammatory Profilin (TGIP) |
| 8/1/2005 | E-140-2005/0 | | Induction of C/EBPalpha and Uses Thereof |
| 8/1/2005 | E-131-2000/0 | | Methods for Reducing Tumor Growth and Metastasis by Inhibiting MCP-1 Activity |
| 8/1/2005 | E-130-1993/0 | 5,861,156 | Methods of Delivering Agents to Target Cells |
| 7/1/2005 | E-132-1988/0 | | Use of 8-C1-cAMP as Anticancer Drug |
| 7/1/2005 | E-208-2005/0 | | Anti-CD30 Antibodies that Bind to Intact CD30 but not to Soluble CD30 |
| 7/1/2005 | E-279-1999/0 | 6,812,246 | Aminoflavone Prodrug |
| 7/1/2005 | E-075-2004/2 | | Methods for the Identification and Use of Compounds Suitable for the Treatment of Drug Resistant Cells |
| 6/1/2005 | E-339-2004/0 | | Framework Residue Substituted Humanized COL-1 Antibodies and Their Use |
| 6/1/2005 | E-106-2004/0 | | Compositions Comprising T Cell Receptors and Methods of Use Thereof |
| 6/1/2005 | E-158-2005/0 | | Identification of H2-Db and HLA-A2 Specific CD8 Epitopes from Human KDR/VEGFR-2 that Inhibit Angiogenesis by Vaccination |
| 6/1/2005 | E-135-2002/1 | 7,470,775 | Novel Anti-CD30 Antibodies and Recombinant Immunotoxins Containing Disulfide-Stabilized Fv Fragments |
| 6/1/2005 | E-320-2001/0 | 7,141,589 | Compositions and Methods for Inhibiting Vascular Channels and Methods of Inhibiting Proliferation |
| 5/1/2005 | E-245-2004/0 | | Methods of Reducing the Activity and Concentration of an Eph Receptor Tyrosine Kinase |
| 5/1/2005 | E-199-1999/0 | | Mycolactone and Related Compounds |
| 4/1/2005 | E-265-1994/0
E-265-1994/1 | 6,255,105
6,342,392
6,737,251
7,067,635 | Nucleotide and Deduced Amino Acid Sequences of a New Tumor Gene, Int6 |
| 4/1/2005 | E-163-1991/2 | 6,797,492 | Method for Reducing the Immunogenicity of Antibody Variable Domains |
| 4/1/2005 | E-107-2005/0 | | Methods for Tumor Treatment Using Dendrimer Conjugates |
| 4/1/2005 | E-117-2005/0 | | Aminoglycosides and Ribosome Inhibitors as Inhibitors of Tyrosyl-DNA-Phosphodiesterase |
| 4/1/2005 | E-072-2005/0 | | Inhibition of Proteosome Function to Potentiate the Proapoptotic and Antitumor Activity of Cytokines |
| 4/1/2005 | E-070-1982/2 | 5,656,587
5,705,477 | Compositions of Transforming Growth Factor Beta (TGF-beta) Which Promotes Wound Healing and Methods for Their Use |
| 4/1/2005 | E-190-2002/2 | 7,485,709 | Identification of Novel Birt-Hogg-Dubé (BHD) Gene |
| 4/1/2005 | E-150-2001/1 | 7,175,838 | Use of a Promoter of T-cell Expansion and an Inducer of CD40 Stimulation in the Treatment or Prevention of a Pathologic State |
| 3/1/2005 | E-001-2005/0 | | Carbohydrate-Encapsulated Gold Nanoparticles as Novel Anti-Metastatic Agents |
| 3/1/2005 | E-206-1992/1 | 5,610,053 | Chromatin Insulator Protecting Expressed Genes of Interest for Human Gene Therapy or Other Mammalian Transgenic Systems |
| 3/1/2005 | E-101-2005/0 | | Karyotypic Complexity as a Determinant of Anti-Cancer Drug Activity |
| 3/1/2005 | E-079-2005/0 | | Inhibition of Human Papillomavirus Type 16 and 18 E6 and E7 Oncogene Expression by E6 and E7-specific siRNAs |
| 3/1/2005 | E-090-1987/0 | | Water-Soluble, Antineoplastic Derivatives of Taxol |
| 3/1/2005 | E-105-2004/0
E-105-2004/1 | | Minimally Immunogenic Germline Sequence Variants of COL-1 Antibody and Their Use |
| 2/1/2005 | E-025-2003/0
E-025-2003/1 | | Methods for Prophylaxis and Treatment of HER-2/neu Tumors |
| 1/1/2005 | E-287-2004/0
E-287-2004/1 | | Mabs to IRTA2 for Use in Diagnosis and Therapy of IRTA-Expressing Cancers |
| 1/1/2005 | E-123-2001/0
E-124-2001/1 | 7,247,615 | Peptide Agonists of Prostate-Specific Antigen and Uses Thereof |
| 1/1/2005 | E-259-2003/0 | | Anti-Proliferative Activity of an Unexpected mTOR Kinase Inhibitor |
| 1/1/2005 | E-191-2003/1 | | Eosinophil-Derived Neurotoxin, an Antimicrobial Protein with Ribonuclease Activity, is an Immunostimulant |
| 1/1/2005 | E-331-2002/0 | | Activation of Recombinant Diphtheria Toxin Fusion Proteins by Specific Proteases Highly Expressed on the Surface of Tumor Cells |
| 1/1/2005 | E-116-2003/0 | 7,541,035 | Immunogenic Peptides for the Treatment of Prostate and Breast Cancer |
| 1/1/2005 | E-051-2003/0 | | Recombinant Immunotoxin and Use in Treating Tumors |
| 12/1/2004 | E-071-2000/0 | 6,468,524 | AAV4 Vector and Uses Thereof |
| 12/1/2004 | E-072-2000/0 | 6,855,314 | AAV5 Vector for Transducing Brain Cells and Lung Cells |
| 10/1/2004 | E-059-2004/0 | | Multimeric Protein Toxins to Target Cells Having Multiple Identifying Characteristics |
| 10/1/2004 | E-220-1993/1 | 5,744,492 | Method for Inhibiting Angiogenesis |
| 9/1/2004 | E-311-2003/0 | | Use of Protein Kinase C Delta Inhibitor, Specifically Rottlerin, Alone or in Further Combination with Staurosporine, in the Treatment of Metastatic Epithelioid Melanoma |
| 8/1/2004 | E-040-1996/0 | 6,734,014
7,378,277 | Methods and Compositions for Transforming Dendritic Cells and Activating T Cells |
| 8/1/2004 | E-325-2001/1
E-325-2001/2 | 6,723,551
7,271,002 | Production of Adeno-Associated Viruses in Insect Cells |
| 8/1/2004 | E-007-2004/0 | 7,511,032 | Adduct Compounds of Pyrrolobenzodiazepinones, Compositions Comprising the Same and Methods Related Thereto |
| 8/1/2004 | E-074-2004/0 | | Methylation Inhibitor Compounds |
| 8/1/2004 | E-230-1999/0 | 6,696,436 | B-Homoestra-1,3,5(10)-trienes as Modulators of Tubulin Polymerization |
| 7/1/2004 | E-090-2003/0 | | Vaccine Peptide Derived from XAGE-1 to Prevent Tumor Growth |
| 6/1/2004 | E-112-1994/0 | 5,652,223
5,981,712
6,790,936 | DNA Encoding CAI Resistance Proteins and Uses Thereof |
| 6/1/2004 | E-325-2002/0 | | Antibodies That Bind POTE and Uses Thereof |
| 5/1/2004 | E-321-2000/0 | | Novel Antisense Oligonucleotides Targeting Folate Receptor Alpha |
| 5/1/2004 | E-002-2002/1 | 7,456,268 | Materials and Methods for Inhibiting Wip1 |
| 4/1/2004 | E-133-2004/0 | | Carbohydrate-Encapsulated Quantum Dots For Cell-Specific Biological Imaging |
| 4/1/2004 | E-326-2002/0
E-326-2002/2 | | Triplex Hairpin Ribozyme |
| 4/1/2004 | E-008-2004/0 | | Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y |
| 3/1/2004 | E-240-1993/0 | 6,699,842 | Dominant Negative Deletion Mutants Of C-Jun And Their Use In The Prevention And Treatment Of Cancer |
| 3/1/2004 | E-231-2002/0 | 7,498,336 | Deazaflavin Compounds and Methods of Use Thereof |
| 3/1/2004 | E-135-1989/0
E-146-1999/0 | 5,696,237
5,863,745
6,051,405
7,521,054 | LMB-2, An Immunotoxin That Shows Efficacy in Phase I Clinical Trials in Treating Patients with Chemotherapy-Resistant Hairy Cell Leukemia and Other Hematologic Malignancies |
| 2/1/2004 | E-244-2002/0 | | Glioma-Selective Polypeptides, Alone or Coupled to a Therapeutic/Diagnostic Agent, Compositions Comprising Same, and Uses Thereof |
| 2/1/2004 | E-037-2001/1 | | Use of IL-13 Inhibitors to Prevent Tumor Recurrence |
| 12/1/2003 | E-297-2002/0 | 7,381,405 | Methods of Preparing Lymphocytes that Express Interleukin-2 and Their Use in the Treatment of Cancer |
| 12/1/2003 | E-227-2002/0 | | Targeting of the Hepatitis A Cellular Receptor to Treat Renal Cancer |
| 12/1/2003 | E-189-2003/0 | | Thalidomide Analogs |
| 12/1/2003 | E-230-2000/0 | 7,432,236 | Vasostatin as Marrow Protectant |
| 11/1/2003 | E-253-2003/0 | | Cytotoxic Indeno- and Isoindenoisoquinoline Compounds |
| 11/1/2003 | E-342-2002/0 | | beta-Defensins as Activators of Dendritic Cells and Vaccine Carrier |
| 11/1/2003 | E-083-2003/0 | | Intracellular Trapping of Radionuclides by Enzyme-Mediated Reduction |
| 11/1/2003 | E-253-2002/0 | | Compositions and Methods for Detecting Abnormal Cell Proliferation |
| 11/1/2003 | E-008-2001/0 | 7,598,077 | Compositions and Methods for Enhancing Differential Gene Expression |
| 11/1/2003 | E-537-1983/2
E-970-1997/0 | | Leukoregulin, An Antitumor Lymphokine, and Its Therapeutic Uses |
| 11/1/2003 | E-169-2003/0 | | Geldanamycin Derivatives with Methyl Substituted Hydrogen Atom at the N22 Position as Anti-Cancer Agents |
| 10/1/2003 | E-001-2003/0
E-001-2003/1
E-019-2003/0 | | Methods and Materials for Controlling Stem Cell and Cancer Cell Proliferation and Differentiation |
| 10/1/2003 | E-294-2002/0 | 7,462,593 | A New Target for Angiogenesis and Anti-Angiogenesis Therapy |
| 9/1/2003 | E-224-2002/0 | | Novel Anti-Tumor and Anti-Fungal Compounds Isolated from Plants of the Genus Aniba |
| 9/1/2003 | E-016-2000/0 | | Cloning and Characterization of VIAF in Several Organisms |
| 8/1/2003 | E-063-2003/0 | | Rapamycin Resistant T Cells and Therapeutic Uses Thereof |
| 6/1/2003 | E-065-1996/2
E-289-1999/0 | 6,187,775
6,541,483
6,664,263 | Imidazoacridones with Anti-Tumor Activity |
| 6/1/2003 | E-091-2002/0 | 7,329,502 | Zap70 Protein Expression as a Marker for Chronic Lymphocytic Leukemia (CLL) |
| 5/1/2003 | E-097-2003/0 | | Triggering Receptors Expressed in Myeloid Cells (TREM) Like Transcript (TLT-1), A Novel Inhibitory Receptor of Platelets and Uses Therefore |
| 5/1/2003 | E-256-2002/0 | | 17-AAG Treatment of Diseases Sensitive to c-KIT Down Regulation |
| 4/1/2003 | E-191-2002/0 | 7,521,475 | Chondropsin-Class Antitumor V-ATPase Inhibitor Compounds, Compositions and Methods of Use Thereof |
| 4/1/2003 | E-063-2002/0 | 7,081,452
7,163,935 | Scorpionate-Like Pendant Macrocyclic Ligands, Complexes and Compositions Thereof, and Methods of Using Same |
| 4/1/2003 | E-060-2000/0
E-060-2000/1 | 4248600
7,488,710 | sFRP and Peptide Motifs That Interact with sFRP and Methods of Their Use |
| 3/1/2003 | E-138-2001/0 | 7,618,789 | Use of Semenogelin in the Diagnosis, Prognosis, and Treatment of Cancer |
| 3/1/2003 | E-057-1994/2 | 5,844,075
6,270,778
6,537,560
6,965,017
7,232,887
7,612,044 | gp100 Cancer Antigens |
| 3/1/2003 | E-052-2002/0 | | Tumor Suppressor Gene Polypeptides and Related Nucleic Acids, Host Cells, Compositions, and Methods of Use in Inhibition of Cell Growth, Modulation of Gene Expression, and Enhancement of Immune-Response Inducing Effect of a Vaccine |
| 1/1/2003 | E-239-2002/0 | | Minimally Immunogenic Variant of Humanized COL-1 Antibody Against Carcinoembryonic Antigen (CEA) |
| 12/1/2002 | E-156-1999/0 | | Pyrimidine Phosphorylase as a Target for Imaging and Therapy |
| 12/1/2002 | E-013-2002/0 | 7,569,673 | Humanized Anti-TAG 72 CC49 for Diagnosis and Therapy of Human Carcinomas |
| 11/1/2002 | E-198-2001/0 | | Use of a Histone Deacetylase Inhibitor to Increase the Entry of an Adenoviral Agent into a Cell |
| 11/1/2002 | E-196-2001/0 | | Use of Interferon-Inducible 2',5'-Oligoadenylate-Dependent RNase in the Diagnosis, Prognosis, and Treatment of Prostate Cancer |
| 11/1/2002 | E-223-1992/0 | 5,359,078
5,482,954
5,498,620
5,705,514 | Signal Transduction Inhibitor Compounds in Clinical Trials as Cancer Therapeutics |
| 9/1/2002 | E-048-2002/0 | | Antiproliferative Actions of Human IGF Binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II |
| 9/1/2002 | E-300-2001/0 | 7,432,349 | New Tumor Suppressor Gene, p28ING5 |
| 8/1/2002 | E-132-1994/0 | 5,942,230
6,197,528 | Retinoids Can Increase the Potency of Anti-Cancer Immunotoxins |
| 7/1/2002 | E-069-2001/0 | 6,756,399 | Use of Lipoxygenase Inhibitors and PPAR Ligands as Anti-Cancer Therapeutic and Intervention Agents |
| 7/1/2002 | E-129-2001/0 | 7,355,012 | Mutated Anti-CD22 Antibodies with Increased Affinity to CD22-Expressing Leukemia Cells |
| 5/1/2002 | E-225-2001/0 | | MRP8, A Member of the ABC Transporter Superfamily Highly Expressed in Breast Cancer, and Uses Thereof |
| 5/1/2002 | E-151-2001/0 | | Method of Promoting Engraftment of a Donor Transplant in a Recipient Host |
| 5/1/2002 | E-344-2001/0 | | The Ovachip: A Clinically Useful cDNA Array for Differential Diagnosis of Ovarian Cancer |
| 4/1/2002 | E-099-2001/0 | | Mitochondrial Topoisomerase I |
| 4/1/2002 | E-051-2002/1 | | Methods for Using Modulators of Extracellular Adenosine or an Adenosine Receptor to Enhance Immune Response and Inflammation |
| 4/1/2002 | E-323-2000/0 | | Activated Dual Specificity Lymphocytes and Their Methods of Use |
| 3/1/2002 | E-360-2001/0 | | Generation and Use of Tc1 and Tc2 Cells |
| 1/1/2002 | E-161-2000/0 | | XAGE-1, A Gene Expressed in Multiple Cancers and Uses Thereof |
| 1/1/2002 | E-286-2000/0 | | Histone Deacetylase Inhibitors in Diagnosis and Treatment of Thyroid Neoplasms |
| 1/1/2002 | E-086-2001/0
E-086-2001/1 | 7,419,957 | Novel Peptides to a Melanoma Antigen and Their Use in Diagnostic and Therapeutic Methods |
| 1/1/2002 | E-002-2001/0 | | Tumor Antigen Homologous to Poly(A) Polymerase |
| 11/1/2001 | E-088-2001/0 | | Diacylglycerol Compounds Useful as Protein Kinase C Activators and Apoptosis Inducers |
| 9/1/2001 | E-033-2001/0 | 7,476,535 | New Isoform of Tyrosinase-Related Protein (TRP-2) that Contains an HLA-A2 Restricted Epitope |
| 8/1/2001 | E-123-2000/0 | | Method of Treating Cutaneous T-Cell Lymphoma by Administering a Histone Deacetylase Inhibitor |
| 6/1/2001 | E-053-2001/0 | | PRAC & PRAC-Y: Small Nuclear Proteins Found in Prostate and Colon Cancer, and Uses Thereof |
| 5/1/2001 | E-203-1994/0 | 5,693,779 | Production and Use of Anti-Dorsalizing Morphogenetic Protein |
| 4/1/2001 | E-011-1994/0 | 5,861,158 | Immunization from an Immunized Allogeneic Bone Marrow Donor |
| 4/1/2001 | E-149-2000/0 | 6,756,215 | Biologically Active FLAG-Epitope-Tagged Transforming Growth Factor Beta (TGF-beta) Protein |
| 4/1/2001 | E-088-1999/0 | 6,949,624 | Cloning of the Human Nuclear Receptor Co-Repressor Gene |
| 2/1/2001 | E-015-2000/0 | | Antiprogestins with Partial Agonist Activity |
| 2/1/2001 | E-237-2000/0 | | RASS1: A Novel Tumor Suppressor Gene Activated by Ras to Promote Apoptosis |
| 2/1/2001 | E-165-1999/0 | | Potentiation of Antineoplastic Agents Using Sigma 2 Ligands |
| 2/1/2001 | E-288-2000/0 | 6,706,867 | The ImmunoChip |
| 2/1/2001 | E-186-2000/0 | 6,932,814 | Radio Frequency Probes for Tissue Treatment and Methods of Use |
| 12/1/2000 | E-134-2000/0 | 7,101,541 | Utilization of Non-Viral Sequences for Minus-Strand DNA Transfer and Gene Reconstitution |
| 12/1/2000 | E-090-2000/0
E-090-2000/1
E-227-2000/0 | 7,619,057 | Novel MHC Class II Restricted T Cell Epitopes from the Cancer Antigen, NY-ESO-1
and
MHC Class II Restricted CD4+ T Cell Epitopes From NY-ESO-1 Presented by DP |
| 12/1/2000 | E-014-2000/0 | 6,600,018
7,223,853 | Secreted Frizzled Related Protein, sFRP, Fragments and Methods of Use Thereof |
| 12/1/2000 | E-196-2000/0 | | Antitumor Immunity Elicited by Defensin-Tumor Antigen Fusions |
| 12/1/2000 | E-194-2000/0 | | Methods and Compositions of Viral Chemokine-Antigen Fusion Proteins as Vaccines for Tumors and AIDS |
| 12/1/2000 | E-192-2000/0 | | HCDS1 Kinase Activates Breast Tumor Suppressor BRCA1 and Promotes DNA Damage Repair |
| 12/1/2000 | E-170-2000/0 | 7,141,661 | NAG-1: A Non-Steroidal Anti-Inflammatory Drug Related Gene Which Has Anti-Tumorigenic Properties |
| 12/1/2000 | E-258-1999/0 | 6,521,635 | Inhibition of MXR Transport by Acridine Derivatives |
| 12/1/2000 | E-259-2000/0 | 6,759,525 | Protein Kinase A and the Carney Complex |
| 9/1/2000 | E-061-1999/0 | | Polypeptides Comprising IL-6 Ligand Binding Receptor Domains and Related Nucleic Acids, Antibodies, Compositions and Methods |
| 9/1/2000 | E-073-1999/0 | 6,737,511 | Receptor-Mediated Uptake of an Extracellular Bcl-XL Fusion Protein Inhibits Apoptosis |
| 7/1/2000 | E-243-1999/0 | | Fibroblast Growth Factor-5 (FGF-5) is a Tumor Associated T-cell Antigen for Human Renal Cell Cancer and Other Adenocarcinomas |
| 7/1/2000 | E-265-1999/0 | 7,132,392 | Inhibition of Cell Motility |
| 6/1/2000 | E-072-1999/0 | 6,765,104 | Transition Metal Complexes of N,N',N''-trialkyl-cis,cis-1,3,5-triaminocyclohexane and Related Compositions and Methods |
| 4/1/2000 | E-201-1992/0 | 5,489,525 | Monoclonal Antibody Specific to Prostate Cells |
| 4/1/2000 | E-194-1998/0 | 6,441,156
6,979,724 | Calcium Channel Compositions and Methods of Use Thereof |
| 9/1/1999 | E-232-1998/0 | 6,613,318
7,005,419
7,125,850 | Methods For Identifying Modulators Of GADD45 Polypeptide Activity |
| 9/1/1999 | E-216-1994/0 | 6,057,346 | Inhibition of Retroviral LTR Promoters by Calcium Response Modifiers |
| 9/1/1999 | E-271-1998/0 | | Methods For Treating Tumors Using Anti-Angiogenic Compounds |
| 8/1/1999 | E-105-1999/0 | 7,226,991 | Phenylalanine Derivatives |
| 8/1/1999 | E-124-1996/0 | 6,323,316
6,608,181
6,831,170
7,297,493 | Fibroblast Growth Factor Receptor Activating Gene 1 (FRAG1), Related Proteins and Methods |
| 7/1/1999 | E-071-1999/0 | 6,696,551
6,995,247 | Ac-HEHA and Related Compounds, Methods of Synthesis and Methods of Use |
| 6/1/1999 | E-058-1997/0 | 6,677,314
6,677,315
6,682,715
6,683,045
6,703,374
6,753,309 | Nucleosides for Imaging and Treatment Applications |
| 6/1/1999 | E-268-1998/0 | 6,423,696 | Modulation of N-Acetyl-Transferase to Improve Therapy and Prevent Cancer |
| 6/1/1999 | E-019-1999/0 | 6,307,090 | Acylated Oligopeptide Derivatives Having Cell Signal Inhibiting Activity |
| 5/1/1999 | E-137-1990/0 | 6,221,620 | Monoclonal Antibodies Specific for Human Thymidylate Synthase |
| 4/1/1999 | E-221-1994/0 | | Peptidomimetic Inhibitors of Cathepsin D and Plasmepsins I and II |
| 4/1/1999 | E-157-1994/1 | 6,787,306
7,402,387 | Method and Composition for Detecting Dihydropyrimidine Dehydrogenase Splicing Mutations |
| 3/1/1999 | E-071-1991/2 | 5,645,988 | Method of Identifying and Using Drugs with Selective Effect Against Cancer Cells |
| 3/1/1999 | E-301-1998/0
E-301-1998/1
E-301-1998/2 | | Combination Therapy With VIP Antagonists |
| 2/1/1999 | E-082-1998/0 | 6,867,180
7,488,711 | Use Of Calreticulin And Calreticulin Fragments To Inhibit Endothelial Cell Growth And Angiogenesis, And Suppress Tumor Growth |
| 12/1/1998 | E-051-1995/0 | 5,702,892
5,824,520 | Method of Inhibiting the Activity of an Intracellular Constituent |
| 12/1/1998 | E-137-1996/0 | 6,326,466 | Double-Stranded RNA Dependent Protein Kinase Derived Peptides To Promote Proliferation Of Cells And Tissues In A Controlled Manner |
| 11/1/1998 | E-385-1986/0 | | Drug and Method for the Therapeutic Treatment of Primary Brain Tumors (Such As Intracranial Human Glioma, Astrocytomas, Medulloblastomas and Metastatic Tumors to the Central Nervous System) |
| 9/1/1998 | E-190-1998/0 | 6,747,055
7,026,350 | Water Soluble Drugs and Method of Preparing Same |
| 7/1/1998 | E-013-1996/0 | 6,235,761 | Compound, Composition, and Method for Treating Cancer |
| 10/1/1997 | E-113-1991/0 | | raf Protein Kinase Therapeutics |
| 10/1/1997 | E-018-1997/0 | 6,562,589
7,232,890 | AIB-1, A Steroid Receptor Co-Activator Amplified In Breast And Ovarian Cancer |
| 8/1/1997 | E-094-1997/0 | 7,358,347 | MEN1, The Gene For Multiple Endocrine Neoplasia Type 1 |
| 5/1/1997 | E-183-1996/0
E-219-1995/0 | 5,831,016
5,840,839
6,083,703
6,087,110
6,132,980
7,001,600
7,015,312 | Novel Human Cancer Antigen of Tyrosinase-Related Proteins 1 and 2 and Genes Encoding Same |
| 4/1/1997 | E-139-1994/0 | 5,637,323 | Method Of Mobilizing Pluripotent Hematopoietic Stem Cells And Accelerating Leukocyte Reconstitution With IL-7 |
| 1/1/1997 | E-051-1994/0
E-051-1994/1 | 5,674,492 | Method Of Preventing Or Treating Disease Characterized By Neoplastic Cells Expressing CD40 |
| 1/1/1997 | E-093-1995/0 | 5,830,755 | T-Cell Receptors And Their Use In Therapeutic And Diagnostic Methods |
| 1/1/1997 | E-221-1995/0 | 6,951,917
7,501,501 | MHC Class II-Restricted Melanoma Antigens And Their Use In Therapeutic Methods |
| 12/1/1996 | E-347-1986/0 | 5,428,154 | Macrocyclic Chelates, and Methods of Use Thereof |
| 11/1/1996 | E-088-1996/0 | | Point Mutated ras Peptides for the Generation of CD8+ Cytotoxic T Lymphocytes |
| 10/1/1996 | E-190-1990/0 | 5,484,889 | Plant Protein Useful For Treating Tumors And HIV Infection |
| 8/1/1996 | E-039-1993/0 | 5,405,782 | A Detection Device and Quantification Method for Therapeutic Agents in Blood |
| 8/1/1996 | E-226-1993/0 | 5,677,275
5,877,148 | Treatment Of Cancer With Human Chorionic Gonadotropin |
| 7/1/1996 | E-188-1992/0 | 5,837,477
5,948,409
5,958,712
6,900,024 | T Cell Receptor Ligands, And Methods For Use |
| 7/1/1996 | E-142-1993/0 | 5,578,566 | Peptide Antagonist Of Keratinocyte Growth Factor Activity |
| 7/1/1996 | E-044-1991/2 | 6,566,098
7,605,127 | Truncated Hepatocyte Growth Factor Variants |
| 7/1/1996 | E-221-1989/0
E-221-1989/1 | 5,183,884
5,480,968
5,820,859
5,916,755
6,639,060 | Novel Epidermal Growth Factor Receptor (ErbB-3) And Antibodies |
| 4/1/1996 | E-184-1993/0 | 5,518,885
5,654,406 | ERBB2 Promoter Binding Protein In Neoplastic Disease |
| 4/1/1996 | E-131-1990/0
E-131-1990/1 | 5,731,301
5,808,038 | Bistriazenes as Chemotherapeutic Agents |
| 4/1/1996 | E-169-1993/0 | 5,990,088 | Method For Treatment Of Kaposi's Sarcoma (KS) By Antisense Oligonucleotides |
| 4/1/1996 | E-024-1995/0 | 5,994,292 | Interferon-Inducible Protein 10 Is A Potent Inhibitor Of Angiogenesis |
| 4/1/1996 | E-001-1989/0 | 5,532,144
6,090,795 | Human Derived Monocyte Attracting Purified Peptide Products For Treating Human Infection And Neoplasms |
| 4/1/1996 | E-053-1995/0
E-053-1995/1 | 5,716,788
5,763,216 | A Gene Encoding a Human Reduced Folate Carrier (RFC) and Methods for the Treatment of Methotrexate-Resistant, Transport-Deficient Cancer Cells |
| 1/1/1994 | E-253-1993/0 | 5,437,951
5,709,996
5,716,620
5,744,142
5,756,284
5,871,998
5,985,610
7,220,419
7,361,356 | Self-Assembling Recombinant Papillomavirus Capsid Proteins |
| 12/1/1993 | E-040-1993/0 | 5,833,986
5,863,739 | Neutralizing Monoclonal Antibody To Human Alpha PDGF Receptors |
| 1/1/1991 | E-493-1985/0
E-493-1985/1 | | 3-Deazaneplanocin, Intermediates for It, and Antiviral Composition and Method of Treatment Using It |